BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26056942)

  • 1. Hispolon inhibits the growth of estrogen receptor positive human breast cancer cells through modulation of estrogen receptor alpha.
    Jang EH; Jang SY; Cho IH; Hong D; Jung B; Park MJ; Kim JH
    Biochem Biophys Res Commun; 2015 Aug; 463(4):917-22. PubMed ID: 26056942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celastrol inhibits the growth of estrogen positive human breast cancer cells through modulation of estrogen receptor α.
    Jang SY; Jang SW; Ko J
    Cancer Lett; 2011 Jan; 300(1):57-65. PubMed ID: 20934245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor.
    Mafuvadze B; Liang Y; Hyder SM
    Oncol Rep; 2014 Oct; 32(4):1727-33. PubMed ID: 25051231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel antiestrogen agent Shikonin inhibits estrogen-dependent gene transcription in human breast cancer cells.
    Yao Y; Zhou Q
    Breast Cancer Res Treat; 2010 May; 121(1):233-40. PubMed ID: 19760501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl-Hispolon from Phellinus lonicerinus (Agaricomycetes) Affects Estrogen Signals in MCF-7 Breast Cancer Cells and Premature Aging in Rats.
    Wang J; Lv H; Chen B; Huang W; Wang A; Liu L; He H; Chen J; Li S; Deng WQ
    Int J Med Mushrooms; 2019; 21(4):381-392. PubMed ID: 31002633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogenic and anti-estrogenic activities of hispolon from Phellinus lonicerinus (Bond.) Bond. et sing.
    Wang J; Hu F; Luo Y; Luo H; Huang N; Cheng F; Deng Z; Deng W; Zou K
    Fitoterapia; 2014 Jun; 95():93-101. PubMed ID: 24637110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hispolon from Phellinus linteus has antiproliferative effects via MDM2-recruited ERK1/2 activity in breast and bladder cancer cells.
    Lu TL; Huang GJ; Lu TJ; Wu JB; Wu CH; Yang TC; Iizuka A; Chen YF
    Food Chem Toxicol; 2009 Aug; 47(8):2013-21. PubMed ID: 19477214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J; Slivova V; Sliva D
    Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of estrogen receptor alpha protein level and survival function by DBC-1.
    Trauernicht AM; Kim SJ; Kim NH; Boyer TG
    Mol Endocrinol; 2007 Jul; 21(7):1526-36. PubMed ID: 17473282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transactivation of ERalpha by Rosiglitazone induces proliferation in breast cancer cells.
    Talbert DR; Allred CD; Zaytseva YY; Kilgore MW
    Breast Cancer Res Treat; 2008 Mar; 108(1):23-33. PubMed ID: 17453334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
    Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
    Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
    Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
    Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
    Laganière J; Deblois G; Giguère V
    Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples.
    Xiong J; Yu D; Wei N; Fu H; Cai T; Huang Y; Wu C; Zheng X; Du Q; Lin D; Liang Z
    FEBS J; 2010 Apr; 277(7):1684-94. PubMed ID: 20180843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue.
    Evers NM; van de Klundert TM; van Aesch YM; Wang S; de Roos WK; Romano A; de Haan LH; Murk AJ; Ederveen AG; Rietjens IM; Groten JP
    Toxicol In Vitro; 2013 Sep; 27(6):1753-61. PubMed ID: 23680332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.
    Travaglini L; Vian L; Billi M; Grignani F; Nervi C
    Int J Biochem Cell Biol; 2009 Jan; 41(1):225-34. PubMed ID: 18789398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.